Dr. Pranjal Kulshreshtha
Qualification : MBBS, MS, DNB,
Department : Surgical Oncologist
Experience : MBBS, MS, DNB,+ Years
Designation : Consultant
Location : India, New Delhi
Hospital(s): Sri Balaji Action Medical Institute New Delhi
About Dr. Pranjal Kulshreshtha
- Dr. Pranjal Kulshreshtha is a trained Surgical Oncologist with 10 years of expertise.
- His interests are Head & Neck, Breast & Thoracic Onco Surgery.
- He is a member of the Indian Association of Surgical Oncology, the Indian Medical Association, the Indian Society of Surgical Oncology, the Association of Surgeons of India and the Delhi Medical Council.
- Dr. Pranjal Kulshreshtha earned his MBBS (2003) from UCMS & GTB Hospital, New Delhi.
- He received his MS (2007) from Safdarjung Hospital, New Delhi.
- He did his DNB (2012) at the Army Hospital Research And Referral, Delhi.
- He has completed successfully MRCS (Glasgow, UK).
- Dr. Pranjal Kulshreshtha is the author of several publications and articles.
Education & Training
- MBBS, 2003, UCMS & GTB Hospital, New Delhi
- MS, 2007, Safdarjung Hospital, New Delhi
- DNB, 2012, Army Hospital Research And Referral, Delhi
Experience
Associate Consultant, Action Cancer Hospital
Clinical Focus
- Metastatic Tumors Treatment
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Bile Duct Cancer Treatment
- Bladder Cancer Treatment
- Breast Cancer-Surgical
- Cancer in Children
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Esophagus Cancer Treatment
- Ewing Family of Tumors Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Leukemia in Children
- Liver Cancer
- Lung Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Small-cell Carcinoma Treatment
- Lung Carcinoid Tumor Treatment
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Nasopharyngeal Cancer Treatment
- Neuroblastoma
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Oral Cavity and Oropharyngeal Cancer
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Salivary Gland Cancer
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Skin Cancer – Melanoma
- Small Intestine Cancer Treatment
- Stomach Cancer Treatment
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Waldenstrom Macroglobulinemia
- Wilms Tumor (Nephroblastoma)
- Pediatric Bone Marrow Transplant
- Oral Cancer – Surgical
- Breast Cancer
- Leukemia Treatment
- Fallopian Tube Cancer
- Ovarian Germ Cell Tumor
- Ovarian Primary Peritoneal Cancer
- Medullary Carcinoma
- Papillary Thyroid Cancer Treatment
- Bone Marrow Cancer
- Ovarian Sex Cord Stromal Tumor
- Invasive Lobular Carcinoma
- Colon Cancer Treatment
- Cancer Treatment
- Adenocarcinoma – Glandular Cancer Treatment
- Immunotherapy
- Breast Conservation Surgery – BCS
- Breast Lumpectomy
- HIPEC
- Parathyroidectomy
- Lobectomy
- Completion Thyroidectomy
Research and Publications
Lung Cancer, Liver Cancer, Colon Cancer, Cervical Cancer, Breast Cancer.
